TISSIUM
↗Paris, France
TISSIUM is a clinical and commercial-stage MedTech company that pioneered a proprietary platform of fully biosynthetic, biomorphic, and programmable polymers for tissue reconstruction. Founded in 2013 as Gecko Biomedical, the company leverages breakthrough research from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women's Hospital) to develop atraumatic surgical solutions.
The company's technology platform is based on a unique family of light-activated, elastomeric polymers (PGSA) that can be used as sealants, adhesives, or 3D-printed implants. TISSIUM operates a fully integrated innovation and manufacturing model, with a state-of-the-art production facility in Roncq, France, and headquarters in Paris and Boston, focusing on three core verticals: peripheral nerve repair, hernia repair, and cardiovascular sealants.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Tissue Reconstruction & Biopolymers
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$10M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series D
Total Raised:$156M
Investors:Cathay Health, Sofinnova Partners, Fonds Stratégique des Transitions (ISALT), Mérieux Développement, Crédit Mutuel Innovation, BNP Paribas Développement, European Investment Fund (EIF)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (FDA De Novo Authorized)
Modalities:Biomorphic Polymers, Light-activated Adhesives, 3D-printed Implants
Active Trials:2
Trial Phases:Phase 2: 1 | Phase 3: 1
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:TISSIUM Inc. (USA)
Key Partnerships:3D Systems (Manufacturing partnership for 3D-printed nerve repair devices), MIT (Foundational IP licensing), Brigham and Women's Hospital (Research collaboration)
COMPETITION
Position:Emerging
Competitors:Axogen, Integra LifeSciences, Polyganics, Checkpoint Surgical, Becton Dickinson (BD), W.L. Gore, Ethicon (Johnson & Johnson)
LEADERSHIP
Key Executives:
Christophe Bancel - Co-Founder & CEO
Maria Pereira - Co-Founder & Chief Innovation Officer
Alex Milstein - Chief Medical Officer
Scientific Founders:Robert Langer, Jeffrey M. Karp
Board Members:Hongjie Hu (Cathay Health), Sara Toyloy (Independent), Antoine Papiernik (Sofinnova Partners)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with TISSIUM. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.